Investigative site

Boston, Massachusetts 02215

1 studies enrolling now · 11 studies all time

What they study most

AIS, Alopecia Areata, Alport Syndrome, Constipation, Focal Segmental Glomerulosclerosis, Irritable Bowel Syndrome With Diarrhea (IBS-D), Lumbosacral Radiculopathy, Multiple Myeloma, Obesity, Opioid-induced Constipation, Overweight, Postherpetic Neuralgia

Studies at this site

• A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism — Recruiting now
• Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis — Completed
• Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata — Completed
• Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes — Completed
• NBP in Adult Patients With Acute Ischemic Stroke (AIS) — Completed
• Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma — Completed
• Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) — Completed
• Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia — Completed
• Phase 2 Efficacy Trial of Z160 in Lumbosacral Radiculopathy — Completed
• Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain. — Stopped early
• Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain — Stopped early